Two Sigma Advisers
CLDX icon

Two Sigma Advisers’s Celldex Therapeutics CLDX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$826K Buy
+40,600
New +$826K ﹤0.01% 1531
2024
Q2
Sell
-14,400
Closed -$604K 2473
2024
Q1
$604K Buy
+14,400
New +$604K ﹤0.01% 1796
2023
Q2
Sell
-36,200
Closed -$1.3M 2416
2023
Q1
$1.3M Sell
36,200
-30,400
-46% -$1.09M ﹤0.01% 1495
2022
Q4
$2.97M Sell
66,600
-53,500
-45% -$2.38M 0.01% 1027
2022
Q3
$3.38M Sell
120,100
-109,800
-48% -$3.09M 0.01% 922
2022
Q2
$6.2M Buy
229,900
+75,900
+49% +$2.05M 0.02% 674
2022
Q1
$5.25M Buy
154,000
+93,700
+155% +$3.19M 0.01% 781
2021
Q4
$2.33M Buy
+60,300
New +$2.33M 0.01% 1117
2021
Q3
Sell
-87,736
Closed -$2.93M 2471
2021
Q2
$2.93M Sell
87,736
-122,520
-58% -$4.1M 0.01% 1113
2021
Q1
$4.33M Sell
210,256
-191,300
-48% -$3.94M 0.01% 911
2020
Q4
$7.04M Sell
401,556
-41,800
-9% -$732K 0.02% 699
2020
Q3
$6.58M Buy
443,356
+387,300
+691% +$5.74M 0.02% 675
2020
Q2
$729K Buy
+56,056
New +$729K ﹤0.01% 1725
2020
Q1
Sell
-16,497
Closed -$37K 2470
2019
Q4
$37K Sell
16,497
-3,900
-19% -$8.75K ﹤0.01% 2300
2019
Q3
$43K Sell
20,397
-6,600
-24% -$13.9K ﹤0.01% 2159
2019
Q2
$72K Sell
26,997
-2,900
-10% -$7.73K ﹤0.01% 2236
2019
Q1
$147K Sell
29,897
-604,853
-95% -$2.97M ﹤0.01% 2158
2018
Q4
$126K Sell
634,750
-4,600
-0.7% -$913 ﹤0.01% 2203
2018
Q3
$288K Buy
639,350
+339,779
+113% +$153K ﹤0.01% 1968
2018
Q2
$151K Buy
299,571
+268,621
+868% +$135K ﹤0.01% 2233
2018
Q1
$72K Sell
30,950
-52,900
-63% -$123K ﹤0.01% 2239
2017
Q4
$238K Buy
+83,850
New +$238K ﹤0.01% 2026
2015
Q1
Sell
-10,350
Closed -$189K 1913
2014
Q4
$189K Buy
+10,350
New +$189K ﹤0.01% 1910